The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA HEALTHCARE COMPANY IN | COM | 00404A109 | 16,903 | 510,666 | SH | SOLE | 510,666 | 0 | 0 | ||
| ADMA BIOLOGICS INC | COM | 000899104 | 6,523 | 1,273,933 | SH | SOLE | 1,273,933 | 0 | 0 | ||
| AMAG PHARMACEUTICALS INC | COM | 00163U106 | 35,736 | 1,026,902 | SH | SOLE | 1,026,902 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 77,161 | 25,052,380 | SH | SOLE | 25,052,380 | 0 | 0 | ||
| ANI PHARMACEUTICALS INC | COM | 00182C103 | 29,801 | 491,608 | SH | SOLE | 491,608 | 0 | 0 | ||
| ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 44,211 | 3,553,943 | SH | SOLE | 3,553,943 | 0 | 0 | ||
| ARRAY BIOPHARMA INC | COM | 04269X105 | 23,912 | 2,723,471 | SH | SOLE | 2,723,471 | 0 | 0 | ||
| ATRICURE INC | COM | 04963C209 | 52,181 | 2,666,354 | SH | SOLE | 2,666,354 | 0 | 0 | ||
| BIOLASE INC | COM | 090911108 | 2,029 | 1,449,022 | SH | SOLE | 1,449,022 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 121,306 | 2,730,887 | SH | SOLE | 2,730,887 | 0 | 0 | ||
| GLOBUS MED INC | CL A | 379577208 | 46,165 | 1,860,000 | SH | SOLE | 1,860,000 | 0 | 0 | ||
| HORIZON PHARMA PLC | SHS | G4617B105 | 93,745 | 5,793,903 | SH | SOLE | 5,793,903 | 0 | 0 | ||
| MALLINCKRODT PUB LTD CO | SHS | G5785G107 | 57,489 | 1,153,944 | SH | SOLE | 1,153,944 | 0 | 0 | ||
| MEDNAX INC | COM | 58502B106 | 43,996 | 660,000 | SH | SOLE | 660,000 | 0 | 0 | ||
| MERRIMACK PHARMACEUTICALS IN | COM | 590328100 | 36,997 | 9,067,998 | SH | SOLE | 9,067,998 | 0 | 0 | ||
| MYRIAD GENETICS INC | COM | 62855J104 | 38,823 | 2,328,932 | SH | SOLE | 2,328,932 | 0 | 0 | ||
| NOVADAQ TECHNOLOGIES INC | COM | 66987G102 | 17,109 | 2,413,179 | SH | SOLE | 2,413,179 | 0 | 0 | ||
| PACIRA PHARMACEUTICALS INC | COM | 695127100 | 20,407 | 631,805 | SH | SOLE | 631,805 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 52,477 | 2,772,156 | SH | SOLE | 2,772,156 | 0 | 0 | ||
| SEASPINE HLDGS CORP | COM | 81255T108 | 1,012 | 128,127 | SH | SOLE | 128,127 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 83,290 | 580,701 | SH | SOLE | 580,701 | 0 | 0 | ||
| VERACYTE INC | COM | 92337F107 | 362 | 46,752 | SH | SOLE | 46,752 | 0 | 0 | ||
| VERICEL CORP | COM | 92346J108 | 8,949 | 2,982,940 | SH | SOLE | 2,982,940 | 0 | 0 | ||